Amylx Pharmaceuticals Inc vs Arko Corp. — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Arko Corp. trades at $4.39 (market cap $493.06M). The key difference: Amylx Pharmaceuticals Inc is far larger — about 5.4× Arko Corp.'s market cap, and Arko Corp. pays a 2.73% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | ARKO | |
|---|---|---|
Market Cap | $2.64B | $493.06M |
Sector | Health | Consumer Cyclical |
52-Week High | $24.19 | $8.64 |
52-Week Low | $7.82 | $3.82 |
Enterprise Value | $2.39B | $2.67B |
Dividend Yield | — | 2.73% |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →ARKO Corp operates as a holding company. The company, through its subsidiaries, owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in three segments: Retail, Wholesale, and GPM Petroleum. The company derives the majority of its revenue from retail and wholesale distribution of fuel.
Read more on ARKO →